Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
01:18pm, Thursday, 10'th Oct 2024
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Thursday, 10'th Oct 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Starboard seeks probe after former Pfizer execs pull support for its campaign
09:26am, Thursday, 10'th Oct 2024
Starboard Value has asked Pfizer to set up a special committee to investigate allegations that two of its former senior executives were forced to publicly declare support for CEO Albert Bourla, the he
Pfizer Skids After Former Execs Flip On Activist Investor, Siding With CEO Albert Bourla
09:24am, Thursday, 10'th Oct 2024
Pfizer stock skidded Thursday after former executives Ian Read and Frank D'Amelio sided with the drugmaker over activist investor Starboard.
Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says
09:19am, Thursday, 10'th Oct 2024
Activist Starboard Value accused Pfizer of threatening litigation against two renegade former executives that initially were supportive of the investor's turnaround campaign at the pharmaceutical gian
Pfizer's stock dips after two former execs say they won't support Starboard, offer backing for CEO Albert Bourla
08:22am, Thursday, 10'th Oct 2024
Pfizer Inc.'s stock dipped early Thursday, after two of its former executives said they would not support an effort by activist shareholder Starboard Value to orchestrate a turnaround.
Pfizer's TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
06:51am, Thursday, 10'th Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the TALAPRO-2 study of TALZENNA® (talazoparib
Pfizer's cancer drug combo improves overall survival in late-stage study
06:47am, Thursday, 10'th Oct 2024
Pfizer said on Thursday a combination of its drugs, Talzenna and Xtandi, helped prolong the lives of patients with a type of advanced prostate cancer in a late-stage study.
2 No-Brainer Healthcare Stocks to Buy With $200 Right Now
05:49am, Thursday, 10'th Oct 2024
Both of these stocks should have plenty of room to run.
Former Pfizer executives not involved in Starboard's campaign against drugmaker
10:48pm, Wednesday, 09'th Oct 2024
Pfizer's former CEO and Chair Ian Read and ex-CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the U.S. drug giant to make chan
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
10:04pm, Wednesday, 09'th Oct 2024
Two former Pfizer executives who were previously linked to activist investor Starboard Value's campaign at the struggling drugmaker said they would step back from the push late Wednesday evening. Form
Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D'Amelio Regarding Starboard Value
09:19pm, Wednesday, 09'th Oct 2024
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Guggenheim Securities, LLC is issuing a statement on behalf of former Pfizer CEO Ian Read and former Pfizer CFO Frank D'Amelio: We have decided not to be in
Why Pfizer Stock Popped Today
06:14pm, Wednesday, 09'th Oct 2024
The sharp, sudden entry of an activist investor is raising hopes that change might come to the company.
Pfizer Declares Fourth-Quarter 2024 Dividend
04:30pm, Wednesday, 09'th Oct 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the company's common stock, payable December 2, 2024, to
Pfizer (PFE) Surges Amid Investor Talks and Legal Victory
10:52am, Wednesday, 09'th Oct 2024
Pfizer (PFE, Financial) experienced a 2.3% increase, reaching $29.85. The rise follows news that Pfizer's CEO plans to meet next week with key leaders from activist investor Starboard Value.
